The Latest Breaking News from StockNews.com

With rising tech spending and the booming global hardware and outsourcing market, the tech industry looks poised for long-term expansion. Hence, fundamentally sound tech stocks Cognizant Technology Solutions (CTSH), Panasonic Holdings (PCRFY), and M-tron Industries (MPTI) might be solid additions to one’s watchlist this week. Read more.

The biotechnology industry thrives with innovation, along with the pharmacy market's expansion powered by digitalization. Hence, it might be ideal to buy fundamentally solid biotech stocks Merck KGaA (MKKGY), Entrada Therapeutics (TRDA), and Gilead Sciences (GILD) for profits and value. Read more to find out….

The pharmaceutical industry is undergoing a transformative shift driven by the advent of personalized drugs, technological innovations, and growing usage. Against this backdrop, does the inclusion of pharma stocks CytomX Therapeutics (CTMX), Merck & Co (MRK), and Neurocrine Biosciences (NBIX) in your portfolio appear wise? Let’s find out….

A resilient economy, characterized by diminished inflation concerns and vigorous consumer spending, is fueling the prosperity of the specialty retail sector. Consequently, which of the two stocks, GameStop (GME) or Aeon Co. (AONNY), could provide better returns this year? Let’s find out….

The entertainment casino industry is benefiting from the unprecedented growth of online gambling activities, rising disposable income, and easy accessibility. Therefore, let’s delve into the fundamentals of entertainment casino stocks Monarch Casino & Resort (MCRI) and DraftKings (DKNG) to gauge their suitability as portfolio additions. Read on….

With increased automation of business operations across several industries, the rising need for customized apps and data security, and technological advancements, the software sector is flourishing. Hence, it could be ideal to watch robust software stocks Akamai Technologies (AKAM), SS&C Technologies (SSNC), and Qualys (QLYS) this week, which have huge…

The pharmaceutical industry holds immense promise due to the rapidly aging population, growing healthcare needs, breakthroughs in new drugs and therapies, and the rise in chronic diseases. Therefore, it could be wise to add fundamentally strong pharma stocks Supernus Pharmaceuticals (SUPN), Eton Pharmaceuticals (ETON), and Viatris (VTRS) to one’s portfolio.…

The semiconductor industry shows great potential for future prosperity amid rising integration of advanced technology, growing chip demand across sectors, and government support. To that end, fundamentally robust chip stocks Amkor Technology (AMKR), United Microelectronics Corporation (UMC), and Infineon Technologies AG (IFNNY) could be solid buys to guard the portfolio…

A wide range of applications across several sectors, supportive government initiatives, rapid technological advancements, and shifting market dynamics position the biotechnology industry for robust long-term growth. Given the industry’s bright outlook, biotech stocks MannKind (MNKD), Illumina (ILMN), and TG Therapeutics (TGTX) could be ideal watchlist additions for potential growth. Read…

The pharmaceutical industry, which experienced significant growth over the past years, is anticipated to remain buoyed, driven by the increasing prevalence of chronic diseases, advancements in medical technology, and rising healthcare awareness and expenditure. Given this backdrop, quality pharma stocks Voyager Therapeutics (VYGR), Sanofi (SNY), and Pacira BioSciences (PCRX), with…

Chipmaker QUALCOMM (QCOM) reported an earnings beat amid a recovering semiconductor market. Let’s look at its financial metrics to gauge whether the stock is exhibiting buy signals. Read on….